AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $136,000 | -31.3% | 12,100 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $198,000 | -7.9% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $215,000 | +33.5% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $161,000 | +18.4% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $136,000 | -46.0% | 12,100 | -2.4% | 0.00% | -50.0% |
| Q3 2019 | $252,000 | -65.0% | 12,400 | -50.0% | 0.00% | -50.0% |
| Q2 2019 | $720,000 | -24.1% | 24,800 | +63.2% | 0.00% | -33.3% |
| Q1 2019 | $948,000 | +114.0% | 15,200 | +22.6% | 0.01% | +100.0% |
| Q4 2018 | $443,000 | -53.3% | 12,400 | -18.4% | 0.00% | -50.0% |
| Q3 2018 | $948,000 | -9.5% | 15,200 | -2.6% | 0.01% | -14.3% |
| Q2 2018 | $1,048,000 | +25.1% | 15,600 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $838,000 | +1.0% | 15,600 | -1.9% | 0.01% | 0.0% |
| Q4 2017 | $830,000 | 0.0% | 15,900 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $830,000 | -2.5% | 15,900 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $851,000 | +17.7% | 15,900 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $723,000 | +11.2% | 15,900 | -7.6% | 0.01% | 0.0% |
| Q4 2016 | $650,000 | +8.5% | 17,200 | +8.2% | 0.01% | 0.0% |
| Q3 2016 | $599,000 | +109.4% | 15,900 | 0.0% | 0.01% | +133.3% |
| Q2 2016 | $286,000 | +74.4% | 15,900 | +17.8% | 0.00% | +50.0% |
| Q1 2016 | $164,000 | -48.8% | 13,500 | +3.1% | 0.00% | -50.0% |
| Q4 2015 | $320,000 | +41.0% | 13,100 | +2.3% | 0.00% | +33.3% |
| Q3 2015 | $227,000 | +9.7% | 12,800 | +9.4% | 0.00% | +50.0% |
| Q2 2015 | $207,000 | -41.5% | 11,700 | +3.5% | 0.00% | -50.0% |
| Q1 2015 | $354,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |